Dr. Fiona Chan is a neurologist with a strong interest in Neuroimmunology and has been awarded multiple accolades for her clinical presentations in this field. Her work in Rituximab in Myasthenia Gravis was recognised by her receipt of the Early Career Researcher Award. As an invited speaker at the National Myasthenia Alliance Conference, Fiona is a keen advocate for the myasthenic patient population. Her beliefs in empowering her patients has led her to work closely with the Myasthenia Gravis Association of Queensland to update the official website with bespoke information on the diagnosis and treatment of myasthenic patients.

She is currently undertaking a Neuroimmunology Fellowship with the Neuroimmunology department at Concord Hospital (NSW) which specialises in the safe treatment of neurological conditions requiring immunotherapy.

Rosie is an experienced General Practitioner and former medical educator for James Cook University Generalist Medical Training. She supervises GP registrars and medical students. I have been a rural GP for 30 years and have encountered many cases of Q fever in that time and been involved with the mass vaccination clinics in the 90s as well as running vaccination clinics through the medical centre for many years.

Dr. Adele Hosseini has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues the strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications.

Dr. Jacqueline Anderson is a Senior Lecturer in Clinical Neuropsychology in the Melbourne School of Psychological Sciences; she is also the Convenor of the School’s Postgraduate Program in Clinical Neuropsychology. As well as undertaking research in the area of concussion, she has 20 years of experience working as a Clinical Neuropsychologist in both the public and private health sectors.

Rebecca works as a Perinatal Psychiatrist in London, dealing with infertility, pregnancy loss, anxiety, depression, OCD and trauma. She’s got experience spanning over twenty years. She developed a particular interest in birth trauma, which led to founding the annual Birth Trauma Conference and Make Birth Better with Emma in 2018.

I have the luxury of working with women all through their pregnancies and beyond. I personally had a really tough pregnancy with hyperemesis, a huge risk factor for birth trauma. And there was a real lack of kindness in my birth. I passionately believe that many of the most important skills are being lost in medicine due to the pressures on the system and burnt out medical staff. I believe that kindness, time and dignity matter very much. What we are building at Make Birth Better is a powerful collective of amazing parents and professionals. We are all equal in this. Together, we must be loud and bold. Birth can, and must be, better. No second best. No excuses. 

As QLD State Practice Group Leader for Slater and Gordon I seek to provide my clients with a clear and effective path through the legal system that delivers the best outcome for their case. I am currently based in the Brisbane Office but manage cases QLD wide.
In the past I have worked in diverse areas of medical malpractice in London and Australia, and for the last ten years’ as a specialist litigation lawyer.
When I work on your case, I utilise more than 20 years’ legal and case knowledge to deeply understand your circumstances, the options for moving forward, and the best strategy for delivering a positive outcome for you and your family. I help you navigate a complex legal system, providing you with knowledge of progress and timeframes. My goal is to remove any potential for additional stress during what can be a challenging period in your life.
As Practice Leader with Slater and Gordon QLD, I am motivated every day by the knowledge I am making a positive impact on my clients’ lives. It is a rewarding experience to help those who have suffered an unexpected loss and providing them with a voice they wouldn’t otherwise have had.
I have firsthand knowledge of the of the challenges and upheaval caused by a life-changing incident for my clients and their families. My goal is to provide an empathetic and supportive approach. I am familiar with the emotional and physical needs of people who are experiencing a difficult time in their life and the legal knowledge to help them get back on track.

Honorary Professorial Fellow
Melbourne School of Psychological Sciences
Faculty of Medicine, Dentistry, and Health Sciences
The University of Melbourne Victoria 3008

Dr Bronwyn Devine is a fertility specialist for over 14 years, obstetrician and gynaecologist with over 25 years’ experience and a special interest in periconceptional medicine and anovulatory infertility.
Bronwyn counts many transgender patients and members of the LGBTQ+ community among her client success stories. She finds her job truly rewarding in the way it allows her to help create families in a variety of ways and she has developed a great deal of expertise in surrogacy and donor gametes.
Relatability and comfortability are crucial to Bronwyn’s bedside manner. For her, patients are best equipped to take this journey when they feel confident in having an open and honest dialogue about their medical history and fertility goals.
Her advice to couples thinking about booking a consult is to seek out an appropriate doctor who is not only specialised but clearly has their patients’ best interests at heart.
Nothing fills Bronwyn with more joy than the moment she is able to hand a new parent their newborn baby after going through IVF, especially so in cases where all hope had previously been lost.

Dr (Elizabeth) Emma Palmer is a Clinical Geneticist at Sydney Children’s Hospitals Network (SCHN) and university lecturer at the University of New South Wales, in Sydney Australia. She is passionate about improving the patient journey for all with rare genetic conditions and their families. Her work aims to improve the recognition of the possibility of genetic conditions by improving clinicain education about rare diseases, maximising the diagnostic yield of genetic tests and optimising patient care by linking families to best practice guidelines, treatments and supports. She has over 45 peer reviewed journal articles, including those describing 9 new genetic conditions.
She leads the following collaborative research programs:
1. Gene2Care, an innovative rare genetic disease program at SCHN, to ensure all families with genetic conditions have the option of participating in research and being linked to undiagnosed disease pathways and clinical trials.
2. GeneEQUAL a co-design project to improve equity and accessibility of genomic testing and counselling to people with intellectual disabilities and
3. CoGENES an interdisciplinary research team improving diagnoses, support and treatments for children with rare genetic epilepsies and their families, and
4. RArEST a collaborative project to improve awareness, education, training and support for rare disease across Australia.
She is also a chief investigator on many national and international rare disease programs including the newly launched national undiagnosed disease program UDN-Aus, the Australian Functional Genomic Network and the Diagnostic Working Group of the Undiagnosed Disease Network International.
She strives to ensure that the patient and family voice is always central to all her research.

Kate is a fertility specialist, gynaecologist and reproductive endocrinologist. She completed university in Melbourne and trained in obstetrics and gynaecology at The Women’s Hospital and The Mercy Hospital, with further work and experience in this field during two years in the UK.

Kate then spent three years specialising in infertility and reproductive endocrinology and is CREI qualified. She has led and participated in many research studies, both at Melbourne IVF and with other researchers. Kate has authored and co-authored over 45 research papers published in scientific journals.
She is Associate Professor of Obstetrics and Gynaecology at the University of Melbourne, Royal Women’s Hospital, and the Head of the Endocrine and Metabolic Service and Acting Head of Reproductive Services both at the Royal Women’s Hospital Melbourne. She is also the Clinical Director and Head of Clinical Research at Melbourne IVF.
Kate’s special interest is in medical fertility preservation and she established and coordinates the Fertility Preservation Services at the Royal Women’s Hospital and Melbourne IVF.
She currently co-chairs the COSA Medical Fertility Preservation Guidance development group and is also a member of the international Pancare working group for development of the European Fertility Preservation Guidelines.
Kate’s patients appreciate her accessibility and strong commitment to research guiding best practice. She is dedicated to ensuring every patient is given the best chance of having a family.

Dr McMahon is a Nephrologist and Executive Clinical Director, Specialty Medicine at Eastern Health Clinical School
Prof McMahon has been principal investigator or co-investigator on many investigator-initiated studies over the last 25 years.

Associate Professor Kelly Allott is a senior research fellow and clinical neuropsychologist and she leads the cognition research at Orygen.

Kelly works mainly with young people who have either had their first experience of psychosis or who are at risk of developing psychosis, but also other disorders including depression. Her research focuses on the role of cognition, including memory, language and reasoning, in youth psychiatric disorders. This work is aimed at helping us understand more about cognition and how cognition affects and influences functional and symptomatic aspects of psychosis and other mental illnesses.

Kelly is developing and trialling youth-friendly interventions that address the barriers to helping young people in their recovery.